headaches from tirzepatide A new clinical trial will offer hope for people living with a debilitating, blinding headache condition Headaches from GLP-1 Injections -

Brooks JO 3rd, Yesavage JA, Carta A, Bravi D

These are usually temporary and subside gradually, but can become severe or intolerable, depending on your health status and your bodys tolerance

People with multiple NAION risk factors such as sleep apnoea, high blood pressure and diabetes should undergo careful consideration with their treating doctor before starting these medications

Another drug in development, retratrutide, works on three receptors: GLP-1, GIP, and the glucagon receptor

Their Diabetes & Metabolism (March 2025) analysis followed more than 670,000 individuals with prior acute pancreatitis and type 2 diabetes